Difference between revisions of "Giant cell tumour of bone"

From Libre Pathology
Jump to navigation Jump to search
(tweak)
(more)
 
(2 intermediate revisions by the same user not shown)
Line 14: Line 14:
| Gross      =
| Gross      =
| Grossing  =
| Grossing  =
| Site      = [[bone]]
| Site      = [[bone]], epiphysis usually
| Assdx      =
| Assdx      =
| Syndromes  =
| Syndromes  =
| Clinicalhx = usu. young adults (20-45 years old)
| Clinicalhx = usu. young adults (20-45 years old)
| Signs      =
| Signs      = +/-immobility
| Symptoms  =
| Symptoms  = +/-pain
| Prevalence =
| Prevalence = uncommon ~ 5% of primary bone tumours
| Bloodwork  =
| Bloodwork  =
| Rads      =
| Rads      =
Line 69: Line 69:


==See also==
==See also==
*[[Bone]].
*[[Chondro-osseous tumours]].
*[[Chondro-osseous tumours]].
*[[Bone]].
*[[Giant cells]].
*[[Giant cell lesions]].
*[[Giant cell lesions]].



Latest revision as of 07:42, 1 October 2013

Giant cell tumour of bone
Diagnosis in short

Giant cell tumour of bone. H&E stain.

LM giant cells (usu. with >10 in the plane of section), mononuclear cells and small multinucleated cells with nuclei similar to those in the giant cells
LM DDx other giant cell lesions
IHC p63 +ve (patchy)
Site bone, epiphysis usually

Clinical history usu. young adults (20-45 years old)
Signs +/-immobility
Symptoms +/-pain
Prevalence uncommon ~ 5% of primary bone tumours

Giant cell tumour of bone is an uncommon bone tumour.

General

Features:[1]

  • Approximately 5% of primary bone tumours.
  • Typical age: 20-45 years.

Clinical

  • Location: growth plate of long bones.[2]
    • May present with joint pain, immobility.

Note:

Microscopic

Features:[3]

  • Giant cells with a large number of nuclei (usu. >10 in the plane of section).
  • Mononuclear cells and small multinucleated cells with nuclei similar to those in the giant cells - key feature.
  • +/-Hemosiderin deposition - not common.[4][5]

Notes:

  • Giant cells typically present in abundance.

DDx:

Images

IHC

  • p63 +ve in scattered mononuclear cells.[6]
    • This seems to be contradicted by another paper.[7]

See also

References

  1. Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 648. ISBN 978-0781765275.
  2. Wülling, M.; Engels, C.; Jesse, N.; Werner, M.; Delling, G.; Kaiser, E. (Aug 2001). "The nature of giant cell tumor of bone.". J Cancer Res Clin Oncol 127 (8): 467-74. PMID 11501745.
  3. Klatt, Edward C. (2006). Robbins and Cotran Atlas of Pathology (1st ed.). Saunders. pp. 420. ISBN 978-1416002741.
  4. Aoki, J.; Moriya, K.; Yamashita, K.; Fujioka, F.; Ishii, K.; Karakida, O.; Imai, S.; Sakai, F. et al. "Giant cell tumors of bone containing large amounts of hemosiderin: MR-pathologic correlation.". J Comput Assist Tomogr 15 (6): 1024-7. PMID 1939753.
  5. Matsushige, T.; Nakaoka, M.; Yahara, K.; Kagawa, K.; Miura, H.; Ohnuma, H.; Kurisu, K. (Aug 2008). "Giant cell tumor of the temporal bone with intratumoral hemorrhage.". J Clin Neurosci 15 (8): 923-7. doi:10.1016/j.jocn.2007.03.013. PMID 18554912.
  6. Dickson BC, Li SQ, Wunder JS, et al. (April 2008). "Giant cell tumor of bone express p63". Mod. Pathol. 21 (4): 369–75. doi:10.1038/modpathol.2008.29. PMID 18311114.
  7. Alberghini M, Kliskey K, Krenacs T, et al. (January 2010). "Morphological and immunophenotypic features of primary and metastatic giant cell tumour of bone". Virchows Arch. 456 (1): 97–103. doi:10.1007/s00428-009-0863-2. PMID 20012988.